Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 23966571)

1.

Peripheral artery disease is an independent predictor of mortality after implantable cardioverter-defibrillator implantation in patients with severe left ventricular dysfunction.

Skeik N, McGriff DM, Katsiyiannis WT, Sullivan TM, Mugglin AS, Retel LM, Hauser RG.

Angiology. 2014 Jul;65(6):507-11. doi: 10.1177/0003319713499607. Epub 2013 Aug 21.

PMID:
23966571
2.
3.

Kidney dysfunction and deterioration of ejection fraction pose independent risk factors for mortality in implantable cardioverter-defibrillator recipients for primary prevention.

Kreuz J, Horlbeck F, Schrickel J, Linhart M, Fimmers R, Mellert F, Nickenig G, Schwab JO.

Clin Cardiol. 2012 Sep;35(9):575-9. doi: 10.1002/clc.22018. Epub 2012 Jun 15.

PMID:
22707222
4.

Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(11):1099-110.

5.

Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.

Zishiri ET, Williams S, Cronin EM, Blackstone EH, Ellis SG, Roselli EE, Smedira NG, Gillinov AM, Glad JA, Tchou PJ, Szymkiewicz SJ, Chung MK.

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):117-28. doi: 10.1161/CIRCEP.112.973552. Epub 2012 Dec 28.

6.

The prognostic impact of pre-implantation hyponatremia on morbidity and mortality among patients with left ventricular dysfunction and implantable cardioverter-defibrillators.

Bhavnani SP, Kumar A, Coleman CI, Guertin D, Yarlagadda RK, Clyne CA, Kluger J.

Europace. 2014 Jan;16(1):47-54. doi: 10.1093/europace/eut211. Epub 2013 Aug 16.

7.

Predictors of sustained ventricular arrhythmias in cardiac resynchronization therapy.

Friedman DJ, Altman RK, Orencole M, Picard MH, Ruskin JN, Singh JP, Heist EK.

Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):762-72. doi: 10.1161/CIRCEP.112.971101. Epub 2012 Jul 11.

8.

Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.

Rienstra M, Smit MD, Nieuwland W, Tan ES, Wiesfeld AC, Anthonio RL, Van den Berg MP, Van Veldhuisen DJ, Van Gelder IC.

Am Heart J. 2007 Jan;153(1):120-6.

PMID:
17174649
9.

Determinants of all-cause mortality in different age groups in patients with severe systolic left ventricular dysfunction receiving an implantable cardioverter defibrillator (from the Italian ClinicalService Multicenter Observational Project).

Fumagalli S, Gasparini M, Landolina M, Lunati M, Boriani G, Proclemer A, Santini M, Mangoni L, Padeletti M, Marchionni N, Padeletti L; Italian ClinicalService Project Centers.

Am J Cardiol. 2014 May 15;113(10):1691-6. doi: 10.1016/j.amjcard.2014.02.025. Epub 2014 Mar 2.

PMID:
24792738
10.

Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.

Martinelli M, de Siqueira SF, Sternick EB, Rassi A Jr, Costa R, Ramires JA, Kalil Filho R.

Am J Cardiol. 2012 Oct 1;110(7):1040-5. doi: 10.1016/j.amjcard.2012.05.040. Epub 2012 Jun 20.

PMID:
22727179
11.

Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).

Zareba W, Piotrowicz K, McNitt S, Moss AJ; MADIT II Investigators.

Am J Cardiol. 2005 Jun 15;95(12):1487-91.

PMID:
15950580
12.

Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML; MADIT-II Investigators.

J Am Coll Cardiol. 2008 Jan 22;51(3):288-96. doi: 10.1016/j.jacc.2007.08.058.

13.

QRS complex widening as a predictor of appropriate implantable cardioverter-defibrillator (ICD) therapy and higher mortality risk in primary prevention ICD patients.

Maciąg A, Przybylski A, Sterliński M, Lewandowski M, Gepner K, Kowalik I, Derejko P, Pytkowski M, Szumowski L, Szwed H.

Kardiol Pol. 2012;70(4):360-8.

14.
15.

Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.

Gatzoulis KA, Vouliotis AI, Tsiachris D, Salourou M, Archontakis S, Dilaveris P, Gialernios T, Arsenos P, Karystinos G, Sideris S, Kallikazaros I, Stefanadis C.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):504-12. doi: 10.1161/CIRCEP.113.000216. Epub 2013 Apr 15.

17.

Implantable cardioverter-defibrillators improve survival after coronary artery bypass grafting in patients with severely impaired left ventricular function.

Al-Dadah AS, Voeller RK, Rahgozar P, Lawton JS, Moon MR, Pasque MK, Damiano RJ Jr, Moazami N.

J Cardiothorac Surg. 2007 Jan 12;2:6.

18.

Left ventricular function improvement after prophylactic implantable cardioverter-defibrillator implantation in patients with non-ischaemic dilated cardiomyopathy.

Grimm W, Timmesfeld N, Efimova E.

Europace. 2013 Nov;15(11):1594-600. doi: 10.1093/europace/eut097. Epub 2013 May 2.

19.

Heart rate turbulence predicts ICD-resistant mortality in ischaemic heart disease.

Marynissen T, Floré V, Heidbuchel H, Nuyens D, Ector J, Willems R.

Europace. 2014 Jul;16(7):1069-77. doi: 10.1093/europace/eut303. Epub 2013 Nov 6.

20.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk